Practice Areas
Mr. Fan is an international partner in the firm's Beijing office. Mr. Fan advises global and Chinese corporate clients and investment funds on mergers and acquisitions, including strategic investments, private equity transactions, foreign direct investments, joint ventures, buyouts, sales, pre-IPO financings, PIPEs and going-private transactions. He also has experience advising on securities offerings and general corporate matters.
Career
Mr. Fan worked at the firm's Beijing office from 2009 to 2010. He then worked at Shearman & Sterling LLP for five years and Davis Polk & Wardwell LLP for almost six years. Before rejoining the firm in 2021, he was a counsel in the corporate practice of Davis Polk & Wardwell LLP.
Work Highlights
Mr. Fan's representative M&A and private equity experience includes: the Tencent-led consortium in its acquisition of a minority stake in Universal Music Group from Vivendi; Heineken in its strategic partnership with China Resources in China; Tencent and Tencent Music Entertainment in their investments in Spotify, and in the cross-shareholding by Spotify in Tencent Music Entertainment; Uber in the merger of Uber China and Didi Chuxing; TPG in its investment in Du Xiaoman Financial; Tencent in its acquisition of a majority stake of China Music Corporation and the combination of QQ Music and China Music Corporation; DouYu in its attempted merger with Huya; IDG Capital in its acquisition of International Data Group; TPG, Warburg Pincus, IDG Capital, Centurium Capital, Bain Capital, I Squared Capital and China Broadband Capital in various private equity investments; pre-IPO financings of Megvii, Tencent Music Entertainment and iQiyi; several China-based companies and SPACs in their respective proposed de-SPAC transactions; Going private transactions of various US-listed companies, including 58.com, 51job.com, China Biologic Products, Sogou, iKang, AsiaInfo-Linkage, Synutra International, KongZhong Corporation, China Nepstar Chain Drugstore, Bona Film, Dangdang, Trunkbow International, Simcere Pharmaceutical, Taomee Holdings and China TransInfo; PIPE investments in China Biologic Products, Qunar and China Cord Blood; JinkoSolar Holding in several rounds of private financing of its downstream solar power project business; L Brands in its acquisition of retail business in beauty products and apparel in China.
Mr. Fan also represented issuers, sponsors and underwriters in capital markets transactions, including US IPOs, Hong Kong IPOs, follow-on offerings, and debt offerings.